Nikolsky sign is a classic physical examination finding in dermatology that indicates fragile intercellular adhesion within the epidermis, resulting in sheet-like epidermal peeling upon the application of a gentle, tangential mechanical sliding force^3,4. First described by the Russian physician Pyotr Vasilyevich Nikolsky in 1896, this bedside maneuver serves as a cornerstone bedside diagnostic indicator to differentiate intraepidermal vesiculobullous dermatoses from subepidermal blistering disorders^3,7. When elicited correctly, the lateral pressure disrupts compromised desmosomal attachments, causing the superficial layer of the skin to dislodge from the underlying basal layer with minimal friction³. This phenomenon reflects underlying acantholysis—the loss of intercellular connections between keratinocytes—or structural necrosis of the epidermis driven by immune-mediated, toxic, or infectious pathologies^2,5. Recognizing a positive Nikolsky sign provides immediate clinical direction for emergency triage, histopathological confirmation, and the prompt initiation of targeted immunosuppressive or supportive therapeutic regimens.

1. Etiology & Risk Factors

• Autoimmune Blistering Dermatoses: Pemphigus vulgaris is the classic autoimmune prototype, characterized by IgG autoantibodies directed against desmoglein 3 and desmoglein 1, resulting in suprabasal acantholysis and a robustly positive Nikolsky sign^3,7. Pemphigus foliaceus features autoantibodies primarily targeting desmoglein 1, manifesting with more superficial subcorneal blistering and fragility⁷.
• Severe Adverse Cutaneous Drug Reactions: Toxic epidermal necrolysis (TEN) and severe Stevens-Johnson syndrome (SJS/TEN overlap) exhibit widespread keratinocyte apoptosis and full-thickness epidermal necrolysis, yielding a profoundly positive Nikolsky sign across extensive body surface areas^5,6. Common offending agents include sulfonamides, aromatic anticonvulsants (phenytoin, carbamazepine), allopurinol, non-steroidal anti-inflammatory drugs (NSAIDs), and certain antiretroviral agents^5,6.
• Toxin-Mediated Bacterial Infections: Staphylococcal scalded skin syndrome (SSSS), or Ritter disease, is driven by epidermolytic toxins (ETA and ETB) produced by specific strains of Staphylococcus aureus². These circulating serine proteases specifically cleave the extracellular domain of desmoglein 1 within the stratum granulosum, yielding a superficial Nikolsky sign particularly prominent in flexural and periorificial friction zones in pediatric populations².
• Paraneoplastic and Genetic Conditions: Paraneoplastic pemphigus and inherited mechanobullous disorders such as certain severe forms of epidermolysis bullosa may occasionally demonstrate altered epidermal resilience, though classic Nikolsky positivity remains diagnostic for acquired acantholytic and necrolytic processes^3,4.

2. Pathophysiology

The pathophysiological basis of a positive Nikolsky sign hinges on the structural failure of intercellular adhesion complexes—specifically desmosomes—or catastrophic keratinocyte death within the epidermal strata^2,5,6. In autoimmune conditions like pemphigus vulgaris, circulating autoantibodies bind to desmosomal cadherins (desmoglein 3 and 1), triggering intracellular signaling cascades, cytoskeletal reorganization, and steric hindrance that disrupts intercellular bonds^3,7. This loss of adhesion leads to suprabasal clefting and intraepidermal acantholysis, creating a cleavage plane where the upper layers of the epidermis float loosely over the basal layer^3,7. In contrast, toxic epidermal necrolysis (TEN) is driven by a dysregulated cytotoxic immune response where drug-specific or hapten-modified antigens expressed on keratinocytes trigger extensive apoptosis^5,6. Activation of the Fas-FasL pathway, perforin-granzyme pathways released by cytotoxic T lymphocytes, and keratinocyte expression of granulysin result in extensive, full-thickness necrosis of the epidermis^5,6. The dermal-epidermal junction detaches en masse, creating large, flaccid bullae and sheets of denuded skin upon minimal mechanical stimulation⁶. In staphylococcal scalded skin syndrome (SSSS), Staphylococcus aureus secretes exfoliative toxins A and B, which act as highly specific glutamic acid-specific serine proteases². These toxins cleave the amino-terminal extracellular domain of desmoglein 1 precisely within the stratum granulosum layer of the epidermis, causing immediate loss of adhesion, superficial blister formation, and widespread skin scaling that mimics thermal burns². When lateral mechanical force is applied to normal-appearing skin adjacent to lesions (perilesional skin) or over intact bullae in any of these conditions, the compromised adhesive planes shear instantly, causing the top layer of skin to wrinkle and slide off, thereby yielding a positive Nikolsky sign^2,3.

3. Clinical Presentation & Classic Clinical Signs

• History & Cardinal Symptoms: Patients typically present with sudden-onset cutaneous pain, skin tenderness, burning sensations, and the rapid development of flaccid blisters, erosions, or extensive areas of denuded skin^2,6. In SSSS, prodromal fever, irritability, and tender cutaneous erythema precede the scalded appearance². In TEN, a prodrome of high fever, ocular burning, and painful swallowing precedes widespread dusky purpuric macules and targetoid lesions that rapidly coalesce^5,6.
• Physical Examination & Named Clinical Signs:
  • Nikolsky Sign: Elicited by applying firm, gentle, tangential sliding pressure with a thumb or finger on normal-appearing perilesional skin or on the roof of an intact blister. Immediate separation, wrinkling, or sliding off of the epidermis confirms a positive sign³.
  • Asboe-Hansen Sign (Bulla Spread Sign): Direct downward pressure applied to the center of an intact bulla causes the fluid to spread peripherally, extending the margin of the blister due to cleavage plane fragility⁴.
  • Nikolsky Variant (Indirect Nikolsky): Gentle traction on the edge of an erosion results in the extension of the denuded area beneath the adjacent normal-appearing stratum corneum.

4. Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

5. Staging, Classification & Clinical Scoring Systems

6. Differential Diagnosis

7. Management & Treatment Protocol

• Initial Stabilization & Resuscitation: Immediate transfer of patients with extensive cutaneous detachment (TEN or severe pemphigus flares) to a specialized Burn Unit or Intensive Care Unit. Establish secure large-bore intravenous access, initiate strict sterile barrier nursing care, maintain ambient room temperature at 30-32°C to prevent hypothermia, and manage fluid and electrolyte replacement guided by Parkland-modified burn resuscitation formulas adjusted for insensible water loss.
• First-Line Medical / Pharmacological Therapy (with exact adult dosing):
  • Autoimmune Blistering Disease (Pemphigus Vulgaris): High-dose oral prednisone (1 to 1.5 mg/kg/day, maximum 80-100 mg daily) combined with a steroid-sparing immunosuppressive agent such as azathioprine (1-2.5 mg/kg/day orally) or mycophenolate mofetil (1-2 g/day orally in divided doses). For refractory or first-line biologic therapy, administer intravenous rituximab (1,000 mg IV infusion on Day 1 and Day 15, repeated at 6 months).
  • Toxic Epidermal Necrolysis (TEN): Immediate discontinuation of all suspect offending drugs. Administer supportive care, non-adherent silicone dressings, and consider immunomodulatory agents such as systemic corticosteroids (e.g., methylprednisolone 1-2 mg/kg/day for short-course pulse therapy) or intravenous immunoglobulin (IVIG at a total dose of 2 g/kg administered over 2-4 days, i.e., 0.5 g/kg/day).
  • Staphylococcal Scalded Skin Syndrome (SSSS): Intravenous antistaphylococcal penicillin or beta-lactamase-resistant penicillin (e.g., nafcillin or oxacillin 2 g IV every 4 hours, or cefazolin 1-2 g IV every 8 hours) combined with supportive emollient skin care and avoidance of topical silver sulfadiazine (which can exacerbate mucosal and skin irritation).
• Surgical / Interventional Indications: Strict avoidance of aggressive surgical debridement in TEN; leave blister roofs intact to act as natural biological dressings. Perform gentle debridement of necrotic sheets only when overtly detached. Consult ophthalmology immediately for emergent management of ocular surface involvement, placement of amniotic membrane grafts, and prevention of symblepharon formation.

8. Complications & Prognosis

• Key acute complications include massive transcutaneous fluid loss leading to hypovolemic shock, acute kidney injury, secondary bacterial sepsis caused by Staphylococcus aureus or Pseudomonas aeruginosa, acute respiratory distress syndrome (ARDS) from airway sloughing, and severe ocular scarring leading to visual impairment or blindness^2,5,6. Chronic complications include cutaneous hyperpigmentation or hypopigmentation, cicatricial alopecia, vulvovaginal strictures, and esophageal webs⁶. Mortality rates in TEN range from 20% to 30%, heavily dictated by patient age, extent of epidermal detachment, and comorbidities as calculated by the SCORTEN score, whereas localized SSSS in pediatric cohorts carries a favorable prognosis with mortality rates below 5% when treated promptly with systemic antibiotics^2,5,6.